<DOC>
	<DOCNO>NCT00597896</DOCNO>
	<brief_summary>The purpose study examine whether medication pramipexole ( Mirapex ) may able improve cognitive problem ( i.e . difficulty think , memory , concentration ) may associate bipolar disorder .</brief_summary>
	<brief_title>Cognitive Enhancement Bipolar Disorder</brief_title>
	<detailed_description>To address primary aim , study eight-week , randomize , double-blind , placebo-controlled treatment trial pramipexole 50 euthymic bipolar I II disorder ( BPD ) patient , demonstrate cognitive impairment .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Subjects 18 65 year age , meet Diagnostic Statistical Manual Mental Disorders , 4th edition ( DSMIV ) criteria BPD I II ( SCID ) confirm diagnostic consensus conference include . Subjects must also meet criterion euthymia describe . All subject must take standard mood stabilizer stable therapeutic dose ( i.e . lithium , carbamazepine , valproate , lamotrigine ) . Subjects history central nervous system ( CNS ) trauma , neurological disorder , Attention Deficit Hyperactivity Disorder ( ADHD ) , learn disability exclude . Subjects DSMIV diagnosis current recent substance abuse dependence ( previous 1 month ) exclude . Moreover , subject rapidcycling past year exclude ( base SCID ) . Any subject active , unstable medical problem may interfere cognition exclude base investigator 's judgment . While medication status important consideration study bipolar disorder , exclusion patient take medication practical , give high prevalence combination pharmacotherapy bipolar disorder . To help control medication effect cognition , plan limit type medication allow exclude certain medication know impact cognitive performance . Subjects take clozapine exclude due 's potential overlapping mechanism action pramipexole . Subjects take prescription overthe counter medication may also exclude medication show impact cognition ( i.e . diphenhydramine ) . The use benzodiazepine , sedative , sleep pill , within 6 hour neurocognitive test allow . In addition , patient take topiramate , tricyclic antidepressant , anticholinergic medication know impact cognition exclude participation . Subjects take medication know interact pramipexole ( i.e . Zantac , Tagamet , Reglan , Benemid , Probalan , Compazine , Phenergan , quinidine , selegiline , verapamil , medication know interaction ) also exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>